Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A probabilistic framework for non-cancer risk assessment.

James J Chen1, Hojin Moon, Ralph L Kodell

  • 1Division of Biometry and Risk Assessment, National Center for Toxicological Research, Food and Drug Administration, Jefferson, AR 72079, USA. jchen@nctr.fda.gov <jchen@nctr.fda.gov>

Regulatory Toxicology and Pharmacology : RTP
|December 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-Guided Chemotherapy Optimization in Lung Cancer Using Genomic and Survival Data.

Journal of personalized medicine·2025
Same author

Prediction of Treatment Recommendations Via Ensemble Machine Learning Algorithms for Non-Small Cell Lung Cancer Patients in Personalized Medicine.

Cancer informatics·2024
Same author

Hf<sub>0.4</sub>Zr<sub>0.6</sub>O<sub>2</sub> Thickness-Dependent Transfer Characteristics of In<sub></sub>Zn<sub>1-</sub>O<sub></sub> Channel Ferroelectric FETs.

The journal of physical chemistry letters·2024
Same author

In vitro and in vivo antiviral effects of CLEVir-X against porcine reproductive and respiratory syndrome virus.

Virus research·2024
Same author

Echocardiography and Management for Cardiac Trauma.

Journal of cardiothoracic and vascular anesthesia·2022
Same author

Identification of Risk Factors and Likelihood of Benefit from Adjuvant Chemotherapy for Early Stage Lung Cancer Patients.

Journal of biopharmaceutical statistics·2019

This study introduces a hierarchical model for probabilistic non-cancer risk assessment. It integrates uncertainty factors and exposure distributions to estimate population risk, using the benchmark dose lower confidence limit (BMDL) as a point of departure (POD).

Area of Science:

  • Environmental Health
  • Toxicology
  • Risk Assessment Modeling

Background:

  • Traditional risk assessment for non-cancer effects relies on uncertainty factors applied to no-observed-adverse-effect levels.
  • Estimating low-dose risks and acceptable exposure levels requires robust methodologies.
  • Current approaches often lack a probabilistic framework to integrate various sources of uncertainty.

Purpose of the Study:

  • To present a novel hierarchical modeling framework for a probabilistic approach to non-cancer risk assessment.
  • To integrate uncertainty factor distributions and exposure level distributions into a dose-response model.
  • To provide a method for estimating the proportion of a population at risk from a given exposure distribution.

Main Methods:

  • Development of a hierarchical modeling framework for probabilistic risk assessment.

Related Experiment Videos

  • Integration of distributions for uncertainty factors and actual exposure levels.
  • Construction of dose-response models for population risk using the benchmark dose lower confidence limit (BMDL) as a point of departure (POD).
  • Main Results:

    • The hierarchical model successfully integrates uncertainty and exposure distributions.
    • The framework allows for the construction of dose-response models for population risk.
    • The approach utilizes the BMDL as a POD for non-cancer risk assessment.

    Conclusions:

    • The proposed probabilistic framework offers a more comprehensive approach to non-cancer risk assessment.
    • This method enhances the estimation of population risk by integrating key uncertainty and exposure parameters.
    • Utilizing BMDL as a POD provides a scientifically sound basis for deriving acceptable exposure levels.